Atherogenic Patheways Mediated by FOXO
Atherogenic Patheways Mediated by FOXO
批准号:
7329717
负责人:
DOMENICO ACCILI
金额:
$55.45万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2012-06-30
关键词:
1-Phosphatidylinositol 3-KinaseAbbreviationsAcetylationAddressAdipocytesAffectApolipoproteins BApoptosisAtherosclerosisBindingCD36 geneCardiovascular DiseasesCause of DeathCholesterolDataDeacetylaseDevelopmentDiabetes MellitusDyslipidemiasFamilyGene ExpressionGene Expression RegulationGenetic TranscriptionGlucoseHeart DiseasesHepaticHistonesHyperglycemiaIndividualInduction of ApoptosisInsulinInsulin ReceptorInsulin ResistanceInvestigationKnock-in MouseKupffer CellsLaboratoriesLigationLinkLipidsLipoproteinsLiverLow Density Lipoprotein ReceptorMacrophage Cell BiologyMapsMediatingMetabolicMetabolic syndromeMetabolismModelingModificationMusMutationNon-Insulin-Dependent Diabetes MellitusOrganPAWR proteinPatientsPhosphorylationPositioning AttributePredispositionProcessPropertyProtein-Serine-Threonine KinasesProteinsProto-Oncogene Proteins c-aktProto-OncogenesPyruvatePyruvatesRNARegulatory ElementRoleSignal TransductionSiteSterolsStressTailTestingTissue ModelTissuesTriglyceridesVery low density lipoproteinatherogenesisbasecell typedeprivationdiabeticexperienceforkhead proteinin vivoinorganic phosphateinterestlifetime risklipid metabolismloss of functionmacrophagemutantnovel strategiesoxidationresearch studyresponse
中文摘要
动脉粥样硬化及其并发症发生较早,在代谢紊乱的患者中更为严重。
综合征和2型糖尿病。心脏病是糖尿病患者死亡的主要原因。的
胰岛素抵抗和高血糖加速动脉粥样硬化的机制尚不清楚,
这些代谢异常促进动脉粥样硬化形成的部位是已知的。PI开发了
组织特异性胰岛素抵抗模型,并建立了胰岛素调节的信号级联反应
通过叉头转录因子FoxO 1的基因表达。拟议的PPG是一个理想的场所,
将Pi在胰岛素作用和胰岛素抵抗模型方面的经验与Tall
和塔巴斯实验室在肝脂蛋白周转、巨噬细胞生物学和
动脉粥样硬化本项目有两个具体目标:目标1将研究FoxO 1依赖性的
肝动脉粥样硬化性血脂异常。PI将检验肝脏胰岛素抵抗通过以下途径起作用的假设:
FoxO 1促进致动脉粥样硬化脂质谱,增加VLDL ApoB分泌。拟议
实验将研究增加的FoxOI依赖性转录对甘油三酯合成的影响,
FFA氧化和脂蛋白周转。体内研究将解决FoxOI是否可以调节
动脉粥样硬化易感性和高血糖对FoxOI活性的作用目标2将研究
FoxO 1/3在巨噬细胞胆固醇负荷诱导未折叠蛋白反应(UPR)中的作用。
胆固醇负荷和SRA连接诱导巨噬细胞UPR。根据Tall博士的初步研究,
和塔巴斯,巨噬细胞中的胰岛素抗性增加了对胆固醇诱导的细胞凋亡的易感性。
这一过程与CD 36、SRA和CHOP表达增加以及AKT和THP表达减少有关。
FoxO磷酸化。PI将产生FoxO 1/3缺陷的巨噬细胞,以检查改变的细胞因子的作用。
FoxOI/3在胆固醇诱导的UPR和动脉粥样硬化中的表达PI将使用RNA分析
FoxOI/3缺陷型巨噬细胞定位FoxO转录靶标并将该信息与
巨噬细胞FoxO 1/3在塔巴斯和Tall项目中的功能分析。这些的结果
研究的目的是提供治疗胰岛素抵抗中脂质异常的新方法,
基于肝脏和巨噬细胞中FoxO活性的调节的2型糖尿病。
英文摘要
Atherosclerosis and its complications occur earlier and are more severe in patients with the metabolic
syndrome and type 2 diabetes. Heart disease is the leading cause of death among diabetics. The
mechanisms by which insulin resistance and hyperglycemia accelerate atherosclerosis are not clear, nor are
the sites at which these metabolic abnormalities promote atherogenesis known. The PI has developed
models of tissue-specific insulin resistance and established a signaling cascade by which insulin regulates
gene expression via the forkhead transcription factor FoxO1. The proposed PPG represents an ideal venue
to integrate the Pi's experience in insulin action and models of insulin resistance with the expertise of the Tall
and Tabas laboratories in studies of hepatic lipoprotein turnover, macrophage cell biology and
atherosclerosis. This project has two Specific Aims: Aim 1 will investigate mechanism of FoxO1-dependent
atherogenic dyslipidemia in liver. The PI will test the hypothesis that hepatic insulin resistance acts through
FoxO1 to promote an atherogenic lipid profile, with increased VLDL ApoB secretion. The proposed
experiments will investigate the effects of increased FoxOI-dependent transcription on triglyceride synthesis,
FFA oxidation and lipoprotein turnover. In vivo studies will address whether FoxOI can modulate the
susceptibilty to atherosclerosis and the role of hyperglycemia on FoxOI activity. Aim 2 will examine the role
of FoxO1/3 in the induction of Unfolded Protein Response (UPR) by cholesterol loading of macrophages.
Cholesterol loading and SRA ligation induce macrophage UPR. As shown in preliminary studies by Drs. Tall
and Tabas, insulin resistance in the macrophage increases susceptibility to cholesterol-induced apoptosis.
This process is associated with increased CD36, SRA and CHOP expression, as well as decreased AKT and
FoxO phosphorylation. The PI will generate FoxO1/3-deficient macrophages to examine the effect of altered
FoxOI/3 expression on cholesterol-induced UPR and atherosclerosis. The PI will use RNA profiling of
FoxOI/3-deficient macrophage to map the FoxO transcriptional targets and integrate this information with
the functional analysis of macrophage FoxO1/3 in the Tabas and Tall projects. The upshot of these
investigations is to provide new approaches to the therapy of lipid abnormalities in insulin resistance and
type 2 diabetes based on the modulation of FoxO activity in liver and macrophages.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mouse Models of Insulin Resistance
-
批准号:10617186
-
项目类别:
-
资助金额:$49.0万
-
财政年份:2020
-
负责人:DOMENICO ACCILI
-
依托单位:
Mouse Models of Insulin Resistance
-
批准号:10207591
-
项目类别:
-
资助金额:$49.0万
-
财政年份:2020
-
负责人:DOMENICO ACCILI
-
依托单位:
Mouse Models of Insulin Resistance
-
批准号:10395560
-
项目类别:
-
资助金额:$49.0万
-
财政年份:2020
-
负责人:DOMENICO ACCILI
-
依托单位:
Mouse Models of Insulin Resistance
-
批准号:10057493
-
项目类别:
-
资助金额:$49.0万
-
财政年份:2020
-
负责人:DOMENICO ACCILI
-
依托单位:
MOUSE MODELS OF INSULIN RESISTANCE
-
批准号:9045751
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2015
-
负责人:DOMENICO ACCILI
-
依托单位:
Diabetes and Endocrinology Research Center
-
批准号:8063347
-
项目类别:
-
资助金额:$6.45万
-
财政年份:2010
-
负责人:DOMENICO ACCILI
-
依托单位:
Insulin Resistance in Vascular Endothelial Cells and Foxo
-
批准号:8460254
-
项目类别:
-
资助金额:$54.01万
-
财政年份:2007
-
负责人:DOMENICO ACCILI
-
依托单位:
PPAR-gamma Deacetylation in Cardiometabolic Disease
-
批准号:10428379
-
项目类别:
-
资助金额:$54.68万
-
财政年份:2007
-
负责人:DOMENICO ACCILI
-
依托单位:
Islet and Immunology
-
批准号:7500528
-
项目类别:
-
资助金额:$12.51万
-
财政年份:2007
-
负责人:DOMENICO ACCILI
-
依托单位:
PPAR-gamma Deacetylation in Cardiometabolic Disease
-
批准号:10197191
-
项目类别:
-
资助金额:$54.68万
-
财政年份:2007
-
负责人:DOMENICO ACCILI
-
依托单位:
Admin Core
-
批准号:7509429
-
项目类别:
-
资助金额:$20.47万
-
财政年份:2007
-
负责人:DOMENICO ACCILI
-
依托单位:
Protein Production Core
-
批准号:7500526
-
项目类别:
-
资助金额:$11.02万
-
财政年份:2007
-
负责人:DOMENICO ACCILI
-
依托单位:
Hormone & Metabolites
-
批准号:7500522
-
项目类别:
-
资助金额:$15.18万
-
财政年份:2007
-
负责人:DOMENICO ACCILI
-
依托单位:
Genomics Core
-
批准号:7500521
-
项目类别:
-
资助金额:$16.52万
-
财政年份:2007
-
负责人:DOMENICO ACCILI
-
依托单位:
Pilot and Feasibility
-
批准号:7500533
-
项目类别:
-
资助金额:$24.23万
-
财政年份:2007
-
负责人:DOMENICO ACCILI
-
依托单位:
Animal Phenotyping
-
批准号:7500530
-
项目类别:
-
资助金额:$15.57万
-
财政年份:2007
-
负责人:DOMENICO ACCILI
-
依托单位:
Insulin Resistance in Vascular Endothelial Cells and Foxo
-
批准号:8996692
-
项目类别:
-
资助金额:$54.01万
-
财政年份:2007
-
负责人:DOMENICO ACCILI
-
依托单位:
Insulin Resistance in Vascular Endothelial Cells and Foxo
-
批准号:8606763
-
项目类别:
-
资助金额:$52.93万
-
财政年份:2007
-
负责人:DOMENICO ACCILI
-
依托单位:
Diabetes and Endocrinology Research Center
-
批准号:6740820
-
项目类别:
-
资助金额:$122.63万
-
财政年份:2003
-
负责人:DOMENICO ACCILI
-
依托单位:
MECHANISMS OF BETA CELL FAILURE
-
批准号:6672380
-
项目类别:
-
资助金额:$40.26万
-
财政年份:2003
-
负责人:DOMENICO ACCILI
-
依托单位:
海外基金